Ennis-based company Vitalograph has today announced the acquisition of Morgan Scientific.
The Massachusetts-based firm is a long-term partner of the respiratory diagnostics leader and its envisaged the move will strengthen Vitalograph’s U.S. commercial footprint and enable it to meet the growing global demand for its innovative solutions.
Morgan Scientific is an expert in customer-facing software for advanced PFT systems, and ComPAS2, the company’s flagship software powers the Ennis-based company’s innovative range of advanced PFT solutions, the VitaloPFT Series.
Morgan Scientific is also a key distributor for Vitalograph’s pulmonary function testing solutions in the US.
The acquisition of the Massachusetts-based firm is a key milestone in Vitalograph’s plan to develop its respiratory diagnostics business globally, furthering its goal of providing comprehensive testing solutions that enable the best possible respiratory healthcare.
In a statement to Clare FM, CEO of Vitalograph, Frank Keane has said the agreement is the natural progression for both companies as their combined expertise allows us them focus on delivering the best possible diagnostic solutions that can enable a better understanding of lung health.
The company is in the middle of an ambitious growth strategy and is said to be on track to treble its respiratory diagnostics business in the four years leading to 2026.
The acquisition coincides with Vitalograph’s 50th anniversary of operating and growing in Ennis, Ireland.
